Transgenic mouse models for myotonic dystrophy type 1 (DM1)

Cytogenetic and Genome Research

Volumn 100, Issue 1-4, 2003, Pages 230-242

  Wansink, D G ^a   Wieringa, B ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; PROTEIN; RNA; TRANSCRIPTION FACTOR;

CELL TYPE; CHROMOSOME 19Q; DISEASE MODEL; DNA RECOMBINATION; DNA REPAIR; DNA REPLICATION; EXPERIMENTAL MODEL; GENE FUNCTION; GENE LOCUS; GENE STRUCTURE; HUMAN; KNOCKOUT GENE; KNOCKOUT MOUSE; MYOTONIC DYSTROPHY; MYOTONIC DYSTROPHY TYPE 1; MYOTONIC DYSTROPHY TYPE 2; NEUROPATHOLOGY; NONHUMAN; NUCLEOTIDE REPEAT; PRIORITY JOURNAL; REVIEW; TRANSGENIC MOUSE; TRANSGENICS;

ANIMALS; DISEASE MODELS, ANIMAL; HOMEODOMAIN PROTEINS; HUMANS; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; MYOTONIC DYSTROPHY; PROTEIN-SERINE-THREONINE KINASES; TRINUCLEOTIDE REPEAT EXPANSION;

ANIMALIA; MUS MUSCULUS;

EID: 0344531040     PISSN: 14248581     EISSN: None     Source Type: Journal    
DOI: 10.1159/000072859     Document Type: Review

References (151)

1. Adachi H, Kume A, Li M, Nakagomi Y, Niwa H, Do J, et al: Transgenic mice with an expanded CAG repeat controlled by the human AR promoter show polyglutamine nuclear inclusions and neuronal dysfunction without neuronal cell death. Hum molec Genet 10:1039-1048 (2001).
2. Alwazzan M, Newman E, Hamshere MG, Brook JD: Myotonic dystrophy is associated with a reduced level of RNA from the DMWD allele adjacent to the expanded repeat. Hum molec Genet 8:1491-1497 (1999).
3. Amack JD, Paguio AP, Mahadevan MS: Cis and trans effects of the myotonic dystrophy (DM) mutation in a cell culture model. Hum molec Genet 8:1975-1984 (1999).
4. Amack JD, Mahadevan MS: The myotonic dystrophy expanded CUG repeat tract is necessary but not sufficient to disrupt C2C12 myoblast differentiation. Hum Mol Genet 10:1879-1887 (2001).
5. Amack JD, Reagan SR, Mahadevan MS: Mutant DMPK 3′-UTR transcripts disrupt C2C12 myogenic differentiation by compromising MyoD. J Cell Biol 159:419-429 (2002).
6. Aslanidis C, Jansen G, Amemiya C, Shutler G, Mahadevan M, Tsilfidis C, et al: Cloning of the essential myotonic dystrophy region and mapping of the putative defect. Nature 355:548-551 (1992).
7. Batten FE, Gibb HP: Myotonica atrophica. Brain 32:187-205 (1909).
8. 2+ homeostasis in skeletal muscle cells. J Clin Invest 100:1440-1447 (1997).
9. Berul CI, Maguire CT, Aronovitz MJ, Greenwood J, Miller C, Gehrmann J, et al: DMPK dosage alterations result in atrioventricular conduction abnormalities in a mouse myotonic dystrophy model. J Clin Invest 103:R1-R7 (1999).
10. Bingham PM, Scott MO, Wang S, McPhaul MJ, Wilson EM, Garbern JY, et al: Stability of an expanded trinucleotide repeat in the androgen receptor gene in transgenic mice. Nature Genet 9:191-196 (1995).
11. 81 is stable in mice. Eur J hum Genet 5:293-298 (1997).
12. 98 repeat in the Fmr1 promoter. Hum molec Genet 10:1693-1699 (2001).
13. n repeat. Hum molec Genet 4:1919-1925 (1995).
14. Bowater RP, Wells RD: The intrinsically unstable life of DNA triplet repeats associated with human hereditary disorders. Prog Nucl Acid Res Mol Biol 66:159-202 (2001).
15. Brewster B, Groenen P, Wieringa B: Myotonic dystrophy: clinical and molecular aspects, in Emery AEH (ed.): Neuromuscular Disorders: Clinical and Molecular Genetics, pp 323-364 (John Wiley & Sons New York 1998).
16. Brock GJ, Anderson NH, Monckton DG: Cis-acting modifiers of expanded CAG/CTG triplet repeat expandability: associations with flanking GC content and proximity to CpG islands. Hum molec Genet 8:1061-1067 (1999).
17. Brook JD, McCurrach ME, Harley HG, Buckler AJ, Church D, Aburatani H, et al: Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3′ end of a transcript encoding a protein kinase family member. Cell 68:799-808 (1992).
18. Buj-Bello A, Furling D, Tronchere H, Laporte J, Lerouge T, Butler-Browne GS, et al: Muscle-specific alternative splicing of myotubularin-related 1 gene is impaired in DM1 muscle cells. Hum molec Genet 11:2297-2307 (2002).
19. Carango P, Noble JE, Marks HG, Funanage VL: Absence of myotonic dystrophy protein kinase (DMPK) mRNA as a result of a triplet repeat expansion in myotonic dystrophy. Genomics 18:340-348 (1993).
20. Chahine M, George AL Jr: Myotonic dystrophy kinase modulates skeletal muscle but not cardiac voltage-gated sodium channels. FEBS Lett 412:621-624 (1997).
21. Charlet-B N, Savkur RS, Singh G, Philips AV, Grice EA, Cooper TA: Loss of the muscle-specific chloride channel in type 1 myotonic dystrophy due to misregulated alternative splicing. Mol Cell 10:45-53 (2002).
22. Davis BM, McCurrach ME, Taneja KL, Singer RH, Housman DE: Expansion of a CUG trinucleotide repeat in the 3′ untranslated region of myotonic dystrophy protein kinase transcripts results in nuclear retention of transcripts. Proc natl Acad Sci, USA 94:7388-7393 (1997).
23. Eriksson M, Ansved T, Edstrom L, Anvret M, Carey N: Simultaneous analysis of expression of the three myotonic dystrophy locus genes in adult skeletal muscle samples: the CTG expansion correlates inversely with DMPK and 59 expression levels, but not DMAHP levels. Hum molec Genet 8:1053-1060 (1999).
24. Eriksson M, Ansved T, Edstrom L, Wells DJ, Watt DJ, Anvret M, et al: Independent regulation of the myotonic dystrophy 1 locus genes postnatally and during adult skeletal muscle regeneration. J biol Chem 275:19964-19969 (2000).
25. Eriksson M, Hedberg B, Carey N, Ansved T: Decreased DMPK transcript levels in myotonic dystrophy 1 type IIA muscle fibers. Biochem biophys Res Commun 286:1177-1182 (2001).
26. Fardaei M, Rogers MT, Thorpe HM, Larkin K, Ham-shere MG, Harper PS, et al: Three proteins, MBNL, MBLL and MBXL, co-localize in vivo with nuclear foci of expanded-repeat transcripts in DM1 and DM2 cells. Hum molec Genet 11:805-814 (2002).
27. Filippova GN, Thienes CP, Penn BH, Cho DH, Hu YJ, Moore JM, et al: CTCF-binding sites flank CTG/CAG repeats and form a methylation-sensitive insulator at the DM1 locus. Nature Genet 28:335-343 (2001).
28. Fortune MT, Vassilopoulos C, Coolbaugh MI, Siciliano MJ, Monckton DG: Dramatic, expansion-biased, age-dependent, tissue-specific somatic mosaicism in a transgenic mouse model of triplet repeat instability. Hum molec Genet 9:439-445 (2000).
29. + channels and Cl conductance in resealed muscle fibre segments from patients with myotonic dystrophy. J Physiol 425:391-405 (1990).
30. Frisch R, Singleton KR, Moses PA, Gonzalez IL, Carango P, Marks HG, et al: Effect of triplet repeat expansion on chromatin structure and expression of DMPK and neighboring genes, SIX5 and DMWD, in myotonic dystrophy. Mol Genet Metab 74:281-291 (2001).
31. Fu Y-H: Identification of a novel protein, DMAP, which interacts with the myotonic dystrophy protein kinase and shows strong homology to D1 snRNP. Genetica 97:117-125 (1996).
32. Fu Y-H, Pizzuti A, Fenwick Jr RG, King J, Rajnarayan S, Dunne PW, et al: An unstable triplet repeat in a gene related to myotonic muscular dystrophy. Science 255:1256-1258 (1992).
33. Fu YH, Friedman DL, Richards S, Pearlman JA, Gibbs RA, Pizzuti A, et al: Decreased expression of myotonin-protein kinase messenger RNA and protein in adult form of myotonic dystrophy. Science 260:235-238 (1993).
34. Galvao R, Mendes-Soares L, Camara J, Jaco I, Carmo-Fonseca M: Triplet repeats, RNA secondary structure and toxic gain-of-function models for pathogenesis. Brain Res Bull 56:191-201 (2001).
35. Gennarelli M, Pavoni M, Amicucci P, Angelini C, Menegazzo E, Zelano G, et al: Reduction of the DM-associated homeo domain protein (DMAHP) mRNA in different brain areas of myotonic dystrophy patients. Neuromuscul Disord 9:215-219 (1999).
36. Godde JS, Wolffe AP: Nucleosome assembly on CTG triplet repeats. J biol Chem 271:15222-15229 (1996).
37. Goldberg YP, Kalchman MA, Metzler M, Nasir J, Zeisler J, Graham R, et al: Absence of disease phenotype and intergenerational stability of the CAG repeat in transgenic mice expressing the human Huntington disease transcript. Hum molec Genet 5:177-185 (1996).
38. Gomes-Pereira M, Fortune MT, Monckton DG: Mouse tissue culture models of unstable triplet repeats: in vitro selection for larger alleles, mutational expansion bias and tissue specificity, but no association with cell division rates. Hum molec Genet 10:845-854 (2001).
39. Gourdon G, Radvanyi F, Lia AS, Duros C, Blanche M, Abitbol M, et al: Moderate intergenerational and somatic instability of a 55-CTG repeat in transgen-ic mice. Nature Genet 15:190-192 (1997).
40. Gregory SG, Sekhon M, Schein J, Zhao S, Osoegawa K, Scott CE, et al: A physical map of the mouse genome. Nature 418:743-750 (2002).
41. Groenen P, Wieringa B: Expanding complexity in myo-tonic dystrophy. BioEssays 20:901-912 (1998).
42. Groenen PJTA, Wansink DG, Coerwinkel M, van den Broek W, Jansen G, Wieringa B: Constitutive and regulated modes of splicing produce six major myotonic dystrophy protein kinase (DMPK) iso-forms with distinct properties. Hum molec Genet 9:605-616 (2000).
43. Hamshere MG, Newman EE, Alwazzan M, Balwinder SA, Brook JD: Transcriptional abnormality in myotonic dystrophy affects DMPK but not neighboring genes. Proc natl Acad Sci, USA 94:7394-7399 (1997).
44. Hanks SK, Hunter T: The eukaryotic protein kinase superfamily: kinase (catalytic) domain structure and classification. FASEB J 9:576-596 (1995).
45. Harper PS: Myotonic dystrophy (WB Saunders, Lon-don 2001).
46. Harris SE, Winchester CL, Johnson KJ: Functional analysis of the homeodomain protein SIX5. Nucl Acids Res 28:1871-1878 (2000).
47. Heath SK, Carne S, Hoyle C, Johnson KJ, Wells DJ: Characterisation of expression of mDMAHP, a homeodomain-encoding gene at the murine DM locus. Hum molec Genet 6:651-657 (1997).
48. Hoeijmakers JH: Genome maintenance mechanisms for preventing cancer. Nature 411:366-374 (2001).
49. Hofmann-Radvanyi H, Lavedan C, Rabes JP, Savoy D, Duros C, Johnson K, et al: Myotonic dystrophy: absence of CTG enlarged transcript in congenital forms, and low expression of the normal allele. Hum molec Genet 2:1263-1266 (1993).
50. IDMC: New nomenclature and DNA testing guidelines for myotonic dystrophy type 1 (DM1). Neurology 54:1218-1221 (2000).
51. Ikeda H, Yamaguchi M, Sugai S, Aze Y, Narumiya S, Kakizuka A: Expanded polyglutamine in the Machado-Joseph disease protein induces cell death in vitro and in vivo. Nature Genet 13:196-202 (1996).
52. Inukai A, Doyu M, Kato T, Liang Y, Kuru S, Yamamoto M, et al: Reduced expression of DMAHP/SIX5 gene in myotonic dystrophy muscle. Muscle Nerve 23:1421-1426 (2000).
53. Ishiguro H, Yamada K, Sawada H, Nishii K, Ichino N, Sawada M, et al: Age-dependent and tissue-specific CAG repeat instability occurs in mouse knock-in for a mutant Huntington's disease gene. J Neurosci Res 65:289-297 (2001).
54. Jansen G, Mahadevan M, Amemiya C, Wormskamp N, Segers B, Hendriks W, et al: Characterization of the myotonic dystrophy region predicts multiple protein isoform-encoding mRNAs. Nature Genet 1:261-266 (1992).
55. Jansen G, Bachner D, Coerwinkel M, Wormskamp N, Hameister H, Wieringa B: Structural organization and developmental expression pattern of the mouse WD-repeat gene DMR-N9 immediately upstream of the myotonic dystrophy locus. Hum molec Genet 4:843-852 (1995).
56. Jansen G, Groenen PJ, Bachner D, Jap PH, Coerwinkel M, Oerlemans F, et al: Abnormal myotonic dystrophy protein kinase levels produce only mild myop-athy in mice. Nature Genet 13:316-324 (1996).
57. Katsuno M, Adachi H, Kume A, Li M, Nakagomi Y, Niwa H, et al: Testosterone reduction prevents phenotypic expression in a transgenic mouse model of spinal and bulbar muscular atrophy. Neuron 35:843-854 (2002).
58. Kawakami K, Ohto H, Takizawa T, Saito T: Identification and expression of six family genes in mouse retina. FEBS Lett 393:259-263 (1996).
59. Kawakami K, Sato S, Ozaki H, Ikeda K: Six family genes - structure and function as transcription factors and their roles in development. BioEssays 22:616-626 (2000).
60. Kaytor MD, Burright EN, Duvick LA, Zoghbi HY, Orr HT: Increased trinucleotide repeat instability with advanced maternal age. Hum molec Genet 6:2135-2139 (1997).
61. Kennedy L, Shelbourne PF: Dramatic mutation instability in HD mouse striatum: does polyglutamine load contribute to cell-specific vulnerability in Huntington's disease? Hum molec Genet 9:2539-2544 (2000).
62. Kirby RJ, Hamilton GM, Finnegan DJ, Johnson KJ, Jarman AP: Drosophila homolog of the myotonic dystrophy-associated gene, SIX5, is required for muscle and gonad development. Curr Biol 11:1044-1049 (2001).
63. Klein HL, Kreuzer KN: Replication, recombination, and repair: going for the gold. Mol Cell 9:471-480 (2002).
64. Klesert TR, Otten AD, Bird TD, Tapscott SJ: Trinucleotide repeat expansion at the myotonic dystrophy locus reduces expression of DMAHP. Nature Genet 16:402-406 (1997).
65. Klesert TR, Cho DH, Clark JI, Maylie J, Adelman J, Snider L, et al: Mice deficient in Six5 develop cataracts: implications for myotonic dystrophy. Nature Genet 25:105-109 (2000).
66. Koob MD, Moseley ML, Schut LJ, Benzow KA, Bird TD, Day JW, et al: An untranslated CTG expansion causes a novel form of spinocerebellar ataxia (SCA8). Nature Genet 21:379-384 (1999).
67. Korade-Mirnics Z, Babitzke P, Hoffman E: Myotonic dystrophy: molecular windows on a complex etiology. Nucl Acids Res 26:1363-1368 (1998).
68. Korade-Mirnics Z, Tarleton J, Servidei S, Casey RR, Gennarelli M, Pegoraro E, et al: Myotonic dystrophy: tissue-specific effect of somatic CTG expansions on allele-specific DMAHP/SIX5 expression. Hum molec Genet 8: 1017-1023 (1999).
69. Kovtun IV, Therneau TM, McMurray CT: Gender of the embryo contributes to CAG instability in transgenic mice containing a Huntington's disease gene. Hum molec Genet 9:2767-2775 (2000).
70. Kovtun IV, Goellner G, McMurray CT: Structural features of trinucleotide repeats associated with DNA expansion. Biochem Cell Biol 79:325-336 (2001).
71. Krahe R, Ashizawa T, Abbruzzese C, Roeder E, Caran-go P, Giacanelli M, et al: Effect of myotonic dystrophy trinucleotide repeat expansion on DMPK transcription and processing. Genomics 28:1-14 (1995).
72. Kwitek AE, Tonellato PJ, Chen D, Gullings-Handley J, Cheng YS, Twigger S, et al: Automated construction of high-density comparative maps between rat, human, and mouse. Genome Res 11:1935-1943 (2001).
73. La Spada AR, Peterson KR, Meadows SA, McClain ME, Jeng G, Chmelar RS, et al: Androgen receptor YAC transgenic mice carrying CAG 45 alleles show trinucleotide repeat instability. Hum molec Genet 7:959-967 (1998).
74. Larkin K, Fardaei M: Myotonic Dystrophy - A multi-gene disorder. Brain Res Bull 56:389-395 (2001).
75. 21 from the fragile X gene remain stable in transgenic mice. Hum Genet 100:407-414 (1997).
76. Lavedan C, Grabczyk E, Usdin K, Nussbaum RL: Long uninterrupted CGG repeats within the first exon of the human FMR1 gene are not intrinsically unstable in transgenic mice. Genomics 50:229-240 (1998).
77. Leeflang EP, Tavare S, Marjoram P, Neal CO, Srinidhi J, MacFarlane H, et al: Analysis of germline mutation spectra at the Huntington's disease locus supports a mitotic mutation mechanism. Hum molec Genet 8:173-183 (1999).
78. Leung T, Chen X-Q, Manser E, Lim L: The p160 RhoA-binding kinase ROKa is a member of a kinase family and is involved in the reorganization of the cytoskeleton. Mol Cell Biol 16:5313-5327 (1996).
79. Leung T, Chen X-Q, Tan I, Manser E, Lim L: Myotonic dystrophy kinase-related Cdc42-binding kinase acts as a Cdc42 effector in promoting cytoskeletal reorganization. Mol Cell Biol 18:130-140 (1998).
80. Lia AS, Seznec H, Hofmann-Radvanyi H, Radvanyi F, Duros C, Saquet C, et al: Somatic instability of the CTG repeat in mice transgenic for the myotonic dystrophy region is age dependent but not correlated to the relative intertissue transcription levels and proliferative capacities. Hum molec Genet 7:1285-1291 (1998).
81. Lipkin SM, Wang V, Jacoby R, Banerjee-Basu S, Baxe-vanis AD, Lynch HT, et al: MLH3: a DNA mismatch repair gene associated with mammalian microsatellite instability. Nature Genet 24:27-35 (2000).
82. Liquori CL, Ricker K, Moseley ML, Jacobsen JF, Kress W, Naylor SL, et al: Myotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9. Science 293:864-867 (2001).
83. Lockington RA, Kelly JM: The WD40-repeat protein CreC interacts with and stabilizes the deubiquitinating enzyme CreB in vivo in Aspergillus nidulans. Mol Microbiol 43:1173-1182 (2002).
84. Lorenzetti D, Watase K, Xu B, Matzuk MM, Orr HT, Zoghbi HY: Repeat instability and motor incoordi-nation in mice with a targeted expanded CAG repeat in the Sca1 locus. Hum molec Genet 9:779-785 (2000).
85. Lu X, Timchenko NA, Timchenko LT: Cardiac elav-type RNA-binding protein (ETR-3) binds to RNA CUG repeats expanded in myotonic dystrophy. Hum molec Genet 8:53-60 (1999).
86. Mahadevan M, Amemiya C, Jansen G, Sabourin L, Baird S, Neville C, et al: Structure and genomic sequence of the myotonic dystrophy (DM kinase) gene. Hum molec Genet 2:299-304 (1993).
87. Mangiarini L, Sathasivam K, Mahal A, Mott R, Seller M, Bates GP: Instability of highly expanded CAG repeats in mice transgenic for the Huntington's disease mutation. Nature Genet 15:197-200 (1997).
88. Mankodi A, Logigian E, Callahan L, McClain C, White R, Henderson D, et al: Myotonic dystrophy in transgenic mice expressing an expanded CUG repeat. Science 289:1769-1772 (2000).
89. Mankodi A, Urbinati CR, Yuan QP, Moxley RT, San-sone V, Krym M, et al: Muscleblind localizes to nuclear foci of aberrant RNA in myotonic dystrophy types 1 and 2. Hum molec Genet 10:2165-2170 (2001).
90. Mankodi A, Takahashi MP, Jiang H, Beck CL, Bowers WJ, Moxley RT, et al: Expanded CUG repeats trigger aberrant splicing of ClC-1 chloride channel pre-mRNA and hyperexcitability of skeletal muscle in myotonic dystrophy. Mol Cell 10:35-44 (2002).
91. Manley K, Pugh J. Messer A: Instability of the CAG repeat in immortalized fibroblast cell cultures from Huntington's disease transgenic mice. Brain Res 835:74-79 (1999a).
92. Manley K, Shirley TL, Flaherty L, Messer A: Msh2 deficiency prevents in vivo somatic instability of the CAG repeat in Huntington disease transgenic mice. Nature Genet 23:471-473 (1999b).
93. n repeat during human fetal development. Hum molec Genet 6:877-880 (1997).
94. Matsui T, Amano M, Yamamoto T, Chihara K, Naka-fuku M, Ito M, et al: Rho-associated kinase, a novel serine/threonine kinase, as a putative target for the small GTP binding protein Rho. EMBO J:2208-2216 (1996).
95. Meola G: Myotonic dystrophies. Curr Opin Neurol 13:519-525 (2000).
96. Michalowski S, Miller JW, Urbinati CR, Paliouras M, Swanson MS, Griffith J: Visualization of double-stranded RNAs from the myotonic dystrophy protein kinase gene and interactions with CUG-binding protein. Nucl Acids Res 27:3534-3542 (1999).
97. n) expansions associated with myotonic dystrophy. EMBO J 19:4439-4448 (2000).
98. Miranda CJ, Santos MM, Ohshima K, Smith J, Li L, Bunting M, et al: Frataxin knockin mouse. FEBS Lett 512:291-297 (2002).
99. Mistry DJ, Moorman JR, Reddy S, Mounsey JP: Skeletal muscle Na currents in mice heterozygous for Six5 deficiency. Physiol Genomics 6:153-158 (2001).
100. Monckton DG, Wong LJ, Ashizawa T, Caskey CT: Somatic mosaicism, germline expansions, germline reversions and intergenerational reductions in myotonic dystrophy males: small pool PCR analyses. Hum molec Genet 4:1-8 (1995).
101. Monckton DG, Coolbaugh MI, Ashizawa KT, Siciliano MJ, Caskey CT: Hypermutable myotonic dystrophy CTG repeats in transgenic mice. Nature Genet 15:193-196 (1997).
102. Monckton DG, Ashizawa T, Siciliano MJ: Murine models for myotonic dystrophy, in Wells RD, Warren ST (eds): Genetic Instabilities and Hereditary Neurological Diseases, pp 181-193 (Academic Press San Diego 1998).
103. Mounsey JP, Xu P, John JE 3rd, Horne LT, Gilbert J, Roses AD, et al: Modulation of skeletal muscle sodium channels by human myotonin protein kinase. J Clin Invest 95:2379-2384 (1995).
104. Mounsey JP, Mistry DJ, Ai CW, Reddy S, Moorman JR: Skeletal muscle sodium channel gating in mice deficient in myotonic dystrophy protein kinase. Hum molec Genet 9:2313-2320 (2000).
105. Moxley RT: Proximal myotonic myopathy: mini-review of a recently delineated clinical disorder. Neuromuscul Disord 6:87-93 (1996).
106. Moxley RT, Udd B, Ricker K: 54th ENMC International Workshop: PROMM (proximal myotonic myopathies) and other proximal myotonic syndromes. 10-12th October 1997, Naarden, The Netherlands. Neuromuscul Disord 8:508-518 (1998).
107. Murakami Y, Ohto H, Ikeda U, Shimada K, Momoi T, Kawakami K: Promoter of mDMAHP/Six5: differential utilization of multiple transcription initiation sites and positive/negative regulatory elements. Hum Mol Genet 7:2103-2112 (1998).
108. Muranyi A, Zhang R, Liu F, Hirano K, Ito M, Epstein HF, et al: Myotonic dystrophy protein kinase phos-phorylates the myosin phosphatase targeting subunit and inhibits myosin phosphatase activity. FEBS Lett 493:80-84 (2001).
109. Nakagawa O, Fujisawa K, Ishizaki T, Saito Y, Nakao K, Narumiya S: ROCK-I and ROCK-II, two iso-forms of Rho-associated coiled-coil forming protein serine/threonine kinase in mice. FEBS Lett 392:189-193 (1996).
110. Narang MA, Waring JD, Sabourin LA, Korneluk RG: Myotonic dystrophy (DM) protein kinase levels in congenital and adult DM patients. Eur J hum Genet 8:507-512 (2000).
111. Neer EJ, Schmidt CJ, Nambudripad R, Smith TF: The ancient regulatory-protein family of WD-repeat proteins. Nature 371:297-300 (1994).
112. Novelli G, Gennarelli M, Zelano G, Pizzuti A, Fattorini C, Caskey CT, et al: Failure in detecting mRNA transcripts from the mutated allele in myo-tonic dystrophy muscle. Biochem molec Biol Int 29:291-297 (1993).
113. Ohto H, Takizawa T, Saito T, Kobayashi M, Ikeda K, Kawakami K: Tissue and developmental distribution of Six family gene products. Int J Dev Biol 42:141-148 (1998).
114. Otten AD, Tapscott SJ: Triplet repeat expansion in myotonic dystrophy alters the adjacent chromatin structure. Proc natl Acad Sci, USA 92:5465-5469 (1995).
115. Philips AV, Timchenko LT, Cooper TA: Disruption of splicing regulated by a CUG-binding protein in myotonic dystrophy. Science 280:737-740 (1998).
116. Ranum LPW, Day JW: Dominantly inherited, non-coding microsatellite expansion disorders. Curr Opin Genet Dev 12:266-271 (2002).
117. Reddy S, Smith DBJ, Rich MM, Leferovich JM, Reilly P, Davis BM, et al: Mice lacking the myotonic dystrophy protein kinase develop a late onset progressive myopathy. Nature Genet 13:325-335 (1996).
118. Reddy S, Mistry DJ, Wang QC, Geddis LM, Kutchai HC, Moorman JR, et al: Effects of age and gene dose on skeletal muscle sodium channel gating in mice deficient in myotonic dystrophy protein kinase. Muscle Nerve 25:850-857 (2002).
119. n triplet repeat RNA-binding protein in patients with myotonic dystrophy and in myotonin protein kinase knockout mice. Proc natl Acad Sci, USA 94:13221-13226 (1997).
120. Sabouri LA, Mahadevan MS, Narang M, Lee DS, Surh LC, Korneluk RG: Effect of the myotonic dystrophy (DM) mutation on mRNA levels of the DM gene. Nature Genet 4:233-238 (1993).
121. Sarkar PS, Appukuttan B, Han J, Ito Y, Ai C, Tsai W, et al: Heterozygous loss of Six5 in mice is sufficient to cause ocular cataracts. Nature Genet 25:110-114 (2000).
122. Sato S, Nakamura M, Cho DH, Tapscott SJ, Ozaki H, Kawakami K: Identification of transcriptional targets for Six5: implication for the pathogenesis of myotonic dystrophy type 1. Hum molec Genet 11:1045-1058 (2002).
123. Sato T, Oyake M, Nakamura K, Nakao K, Fukusima Y, Onodera O, et al: Transgenic mice harboring a full-length human mutant DRPLA gene exhibit age-dependent intergenerational and somatic instabilities of CAG repeats comparable with those in DRPLA patients. Hum molec Genet 8:99-106 (1999).
124. Savkur RS, Philips A, Cooper TA: Aberrant regulation of insulin receptor alternative splicing is associated with insulin resistance in myotonic dystrophy. Nature Genet 29:40-47 (2001).
125. Sergeant N, Sablonniere B, Schraen-Maschke S, Ghes-tem A, Maurage C, Wattez A, et al: Dysregulation of human brain microtubule-associated tau mRNA maturation in myotonic dystrophy type 1. Hum molec Genet 10:2143-2155 (2001).
126. Seznec H, Lia-Baldini AS, Duros C, Fouquet C, La-croix C, Hofmann-Radvanyi H, et al: Transgenic mice carrying large human genomic sequences with expanded CTG repeat mimic closely the DM CTG repeat intergenerational and somatic instability. Hum molec Genet 9:1185-1194 (2000).
127. Seznec H, Agbulut O, Sergeant N, Savouret C, Ghestem A, Tabti N, et al: Mice transgenic for the human myotonic dystrophy region with expanded CTG repeats display muscular and brain abnormalities. Hum molec Genet 10:2717-2726 (2001).
128. Shaw DJ, McCurrach M, Rundle SA, Harley HG, Crow SR, Sohn R, et al: Genomic organization and transcriptional units at the myotonic dystrophy locus. Genomics 18:673-679 (1993).
129. Shelbourne PF, Killeen N, Hevner RF, Johnston HM, Tecott L, Lewandoski M, et al: A Huntington's disease CAG expansion at the murineHdhlocus is unstable and associated with behavioural abnormalities in mice. Hum molec Genet 8: 763-774 (1999).
130. Smith TF, Gaitatzes C, Saxena K, Neer EJ: The WD repeat: a common architecture for diverse functions. Trends Biochem Sci 24:181-185 (1999).
131. Steinbach P, Glaser D, Vogel W, Wolf M, Schwemmle S: The DMPK gene of severely affected myotonic dystrophy patients is hypermethylated proximal to the largely expanded CTG repeat. Am J hum Genet 62:278-285 (1998).
132. Steinert H: Myopathologische Beiträge 1. Über das klinische und anatomische Bild des Muskel-schwunds der Myotoniker. Dtsch Z Nervenheilkd 37:58-104 (1909).
133. Suzuki A, Sugiyama Y, Hayashi Y, Nyui N, Yoshida M, Nonaka I, et al: MKBP, a novel member of the small heat shock protein family, binds and activates the myotonic dystrophy protein kinase. J Cell Biol 140:1113-1124 (1998).
134. Taneja KL, McCurrach M, Schalling M, Housman D, Singer RH: Foci of trinucleotide repeat transcripts in nuclei of myotonic dystrophy cells and tissues. J Cell Biol 128:995-1002 (1995).
135. Tapscott SJ, Thornton CA: Reconstructing myotonic dystrophy. Science 293:816-817 (2001).
136. Thornton CA, Johnson K, Moxley RT: Myotonic dystrophy patients have larger CTG expansions in skeletal muscle than in leukocytes. Ann Neurol 35:104-107 (1994).
137. Thornton CA, Wymer JP, Simmons Z, McClain C, Moxley RT: Expansion of the myotonic dystrophy CTG repeat reduces expression of the flanking DMAHP gene. Nature Genet 16:407-409 (1997).
138. Tian B, White RJ, Xia T, Welle S, Turner DH, Mathews MB, et al: Expanded CUG repeat RNAs form hairpins that activate the double-stranded RNA-dependent protein kinase PKR. RNA 6:79-87 (2000).
139. Timchenko L, Nastainczyk N, Schneider T, Patel B, Hofmann F, Caskey CT: Full-length myotonin protein kinase (72 kDa) displays serine kinase activity. Proc natl Acad Sci, USA 92:5366-5370 (1995).
140. n triplet repeat RNA-binding protein and its expression in myotonic dystrophy. Nucl Acids Res 24:4407-4414 (1996).
141. Tiscornia G, Mahadevan MS: Myotonic dystrophy: the role of the CUG triplet repeats in splicing of a novel DMPK exon and altered cytoplasmic DMPK mRNA isoform ratios. Mol Cell 5:959-967 (2000).
142. Ueda H, Ohno S, Kobayashi T: Myotonic dystrophy and myotonic dystrophy protein kinase. Prog Histochem Cytochem 35:187-251 (2000).
143. n repeat in myotonic dystrophy knock-in mice is differentially affected by Msh3 and Msh6 mismatch-repair proteins. Hum molec Genet 11:191-198 (2002).
144. Vermersch P, Sergeant N, Ruchoux MM, Hofmann-Radvanyi H, Wattez A, Petit H, et al: Specific tau variants in the brains of patients with myotonic dystrophy. Neurology 47:711-717 (1996).
145. Wang J, Pegoraro E, Menegazzo E, Gennarelli M, Hoop RC, Angelini C, et al: Myotonic dystrophy: evidence for a possible dominant-negative RNA mutation. Hum molec Genet 4:599-606 (1995).
146. Wang YH, Amirhaeri S, Kang S, Wells RD, Griffith JD: Preferential nucleosome assembly at DNA triplet repeats from the myotonic dystrophy gene. Science 265:669-671 (1994).
147. Wang YH, Griffith J: Expanded CTG triplet blocks from the myotonic dystrophy gene create the strongest known natural nucleosome positioning elements. Genomics 25:570-573 (1995).
148. Wheeler VC, Auerbach W, White JK, Srinidhi J, Auer-bach A, Ryan A, et al: Length-dependent gametic CAG repeat instability in the Huntington's disease knock-in mouse. Hum molec Genet 8:115-122 (1999).
149. Winchester CL, Ferrier RK, Sermoni A, Clark BJ, Johnson KJ: Characterization of the expression of DMPK and SIX5 in the human eye and implications for pathogenesis in myotonic dystrophy. Hum molec Genet 8:481-492 (1999).
150. Wong LJ, Ashizawa T, Monckton DG, Caskey CT, Richards CS: Somatic heterogeneity of the CTG repeat in myotonic dystrophy is age and size dependent. Am J hum Genet 56:114-122 (1995).
151. Zhang Y, Monckton DG, Siciliano MJ, Connor TH, Meistrich ML: Age and insertion site dependence of repeat number instability of a human DM1 transgene in individual mouse sperm. Hum molec Genet 11:791-798 (2002).